Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
University of Nebraska
Thomas Jefferson University
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
University of Rochester
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Virginia Commonwealth University